173 related articles for article (PubMed ID: 26886128)
1. The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis.
Fishman P; Cohen S
Clin Rheumatol; 2016 Sep; 35(9):2359-62. PubMed ID: 26886128
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P
Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059
[TBL] [Abstract][Full Text] [Related]
3. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.
Silverman MH; Strand V; Markovits D; Nahir M; Reitblat T; Molad Y; Rosner I; Rozenbaum M; Mader R; Adawi M; Caspi D; Tishler M; Langevitz P; Rubinow A; Friedman J; Green L; Tanay A; Ochaion A; Cohen S; Kerns WD; Cohn I; Fishman-Furman S; Farbstein M; Yehuda SB; Fishman P
J Rheumatol; 2008 Jan; 35(1):41-8. PubMed ID: 18050382
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
Madi L; Cohen S; Ochayin A; Bar-Yehuda S; Barer F; Fishman P
J Rheumatol; 2007 Jan; 34(1):20-6. PubMed ID: 17216675
[TBL] [Abstract][Full Text] [Related]
5. Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
Baharav E; Bar-Yehuda S; Madi L; Silberman D; Rath-Wolfson L; Halpren M; Ochaion A; Weinberger A; Fishman P
J Rheumatol; 2005 Mar; 32(3):469-76. PubMed ID: 15742438
[TBL] [Abstract][Full Text] [Related]
6. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease.
Ochaion A; Bar-Yehuda S; Cohen S; Barer F; Patoka R; Amital H; Reitblat T; Reitblat A; Ophir J; Konfino I; Chowers Y; Ben-Horin S; Fishman P
Cell Immunol; 2009; 258(2):115-22. PubMed ID: 19426966
[TBL] [Abstract][Full Text] [Related]
8. A
Jacobson KA; Merighi S; Varani K; Borea PA; Baraldi S; Aghazadeh Tabrizi M; Romagnoli R; Baraldi PG; Ciancetta A; Tosh DK; Gao ZG; Gessi S
Med Res Rev; 2018 Jul; 38(4):1031-1072. PubMed ID: 28682469
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A
Cohen S; Barer F; Itzhak I; Silverman MH; Fishman P
J Immunol Res; 2018; 2018():2310970. PubMed ID: 29862305
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.
Bar-Yehuda S; Luger D; Ochaion A; Cohen S; Patokaa R; Zozulya G; Silver PB; de Morales JM; Caspi RR; Fishman P
Int J Mol Med; 2011 Nov; 28(5):727-31. PubMed ID: 21887476
[TBL] [Abstract][Full Text] [Related]
11. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.
Bar-Yehuda S; Silverman MH; Kerns WD; Ochaion A; Cohen S; Fishman P
Expert Opin Investig Drugs; 2007 Oct; 16(10):1601-13. PubMed ID: 17922624
[TBL] [Abstract][Full Text] [Related]
13. Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment.
Bar-Yehuda S; Rath-Wolfson L; Del Valle L; Ochaion A; Cohen S; Patoka R; Zozulya G; Barer F; Atar E; Piña-Oviedo S; Perez-Liz G; Castel D; Fishman P
Arthritis Rheum; 2009 Oct; 60(10):3061-71. PubMed ID: 19790055
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of the human A
Storme J; Cannaert A; Van Craenenbroeck K; Stove CP
Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765
[TBL] [Abstract][Full Text] [Related]
15. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
[TBL] [Abstract][Full Text] [Related]
16. Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data.
Fishman P
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744805
[TBL] [Abstract][Full Text] [Related]
17. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
[TBL] [Abstract][Full Text] [Related]
18. Role and Function of A
Ravani A; Vincenzi F; Bortoluzzi A; Padovan M; Pasquini S; Gessi S; Merighi S; Borea PA; Govoni M; Varani K
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28338619
[TBL] [Abstract][Full Text] [Related]
19. Targeting the A3 adenosine receptor for glaucoma treatment (review).
Fishman P; Cohen S; Bar-Yehuda S
Mol Med Rep; 2013 Jun; 7(6):1723-5. PubMed ID: 23563604
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structures of adenosine receptor A
Cai H; Guo S; Xu Y; Sun J; Li J; Xia Z; Jiang Y; Xie X; Xu HE
Nat Commun; 2024 Apr; 15(1):3252. PubMed ID: 38627384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
